Fluicell AB announced that it has received funding from Almi Invest AB
On October 7, 2013, Avalance Biotech closed the transaction.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0924 SEK | -0.22% |
|
+0.87% | -85.38% |
05-10 | Fluicell AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-08 | Fluicell AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-85.38% | 4M | |
+40.80% | 53.67B | |
+34.52% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |